Monkey organ-cultured anterior segments: Technique and response to H-7

Experimental Eye Research

Volumn 82, Issue 6 SPEC. ISS., 2006, Pages 1100-1108

  Hu, Yujie ^a   Gabelt, B'Ann True ^a   Kaufman, Paul L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

H 7; monkey; organ cultured anterior segments; outflow facility; trabecular meshwork

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE;

ANALYSIS OF VARIANCE; ANTERIOR EYE SEGMENT; ARTICLE; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INTRAOCULAR PRESSURE; MALE; MONKEY; NONHUMAN; ORGAN CULTURE TECHNIQUE; PERFUSION; PRESSURE; PRIORITY JOURNAL; RHESUS MONKEY; SPECIES DIFFERENCE; SWINE; TRABECULAR MESHWORK;

EID: 33646196705     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2005.12.004     Document Type: Article

References (53)

1. Acott T.S., Westcott M., Passo M.S., and Van Buskirk E.M. Trabecular meshwork glycosaminoglycans in human and cynomolgus monkey eye. Invest. Ophthalmol. Vis. Sci. 26 (1985) 1320-1329
2. Bahler C.K., Hann C.R., Fautsch M.P., and Johnson D.H. Pharmacologic disruption of Schlemm's canal cells and outflow facility in anterior segments of human eyes. Invest. Ophthalmol. Vis. Sci. 45 (2004) 2246-2254
3. Bahler C.K., Fautsch M.P., Hann C.R., and Johnson D.H. Factors influencing intraocular pressure in cultured human anterior segments. Invest. Ophthalmol. Vis. Sci. 45 (2004) 3137-3143
4. Bárány E.H. Simultaneous measurement of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion. Invest. Ophthalmol. 3 (1964) 135-143
5. Borrás T., Rowlette L.L., Erzurum S.C., and Epstein D.L. Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucoma. Gene Ther. 6 (1999) 515-524
6. Brubaker R.F. The effect of intraocular pressure on conventional outflow resistance in the enucleated human eye. Invest. Ophthalmol. 14 (1975) 286-292
7. Clark A.F., Wilson K., de Kater A.W., Allingham R.R., and McCartney M.D. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Invest. Ophthalmol. Vis. Sci. 36 (1995) 478-489
8. Dijkstra B.G., Ruijter J.M., and Hoyng P.F. Outflow characteristics of isolated anterior segments of human eyes. Invest. Ophthalmol. Vis. Sci. 37 (1996) 2015-2021
9. Epstein D.L., Roberts B.C., and Skinner L.L. Nonsulfhdryl-reactive phenoxyacetic acids increase aqueous humor outflow facility. Invest. Ophthalmol. Vis. Sci. 38 (1997) 1526-1534
10. Epstein D.L., Rowlette L.-L., and Roberts B.C. Acto-myosin drug effects and aqueous outflow function. Invest. Ophthalmol. Vis. Sci. 40 (1999) 74-81
11. Erickson-Lamy K.A., Kaufman P.L., McDermott M.L., and France N.K. Comparative anesthetic effects on aqueous humor dynamics in the cynomolgus monkey. Arch. Ophthalmol. 102 (1984) 1815-1820
12. Erickson-Lamy K., Rohen J.W., and Grant W.M. Outflow facility studies in the perfused bovine aqueous outflow pathways. Curr. Eye Res. 7 (1988) 799-807
13. Erickson-Lamy K., Schroeder A.M., Bassett-Chu S., and Epstein D.L. Absence of time-dependent facility increase ('wash-out') in the perfused enucleated human eye. Invest. Ophthalmol. Vis. Sci. 31 (1990) 2384-2388
14. Erickson-Lamy K., Rohen J.W., and Grant W.M. Outflow facility studies in the perfused human ocular anterior segment. Exp. Eye Res. 52 (1991) 723-731
15. Ethier C.R., and Chan D.W. Cationic ferritin changes outflow facility in human eyes whereas anionic ferritin does not. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1795-1802
16. Ethier C.R., Ajersch P., and Pirog R. An improved ocular perfusion system. Curr. Eye Res. 12 (1993) 765-770
17. Freddo T.F. The Glenn A. Fry Award Lecture 1992: aqueous humor proteins: a key for unlocking glaucoma?. Optom. Vis. Sci. 70 (1993) 263-270
18. 2α on trabecular outflow facility in cynomolgus monkeys. Exp. Eye Res. 51 (1990) 87-91
19. Gabelt B.T., Crawford K., and Kaufman P.L. Outflow facility and its response to pilocarpine decline in aging rhesus monkeys. Arch. Ophthalmol. 109 (1991) 879-882
20. Goldwich A., Ethier C.R., Chan D.W., and Tamm E.R. Perfusion with the olfactomedin domain of myocilin does not affect outflow facility. Invest. Ophthalmol. Vis. Sci. 44 (2003) 1953-1961
21. Gottanka J., Chan D., Eichhorn M., Lutjen-Drocoll E., and Ethier C.R. Effects of TGF-beta2 in perfused human eyes. Invest. Ophthalmol. Vis. Sci. 45 (2004) 153-158
22. Grant W.M. Experimental aqueous perfusion in enucleated human eyes. Arch. Ophthalmol. 69 (1963) 783-801
23. Gual A., Llobet A., Gilabert R., Borras M., Pales J., Bergamini M.V., and Belmonte C. Effects of time of storage, albumin, and osmolality changes on outflow facility (C) of bovine anterior segment in vitro. Invest. Ophthalmol. Vis. Sci. 38 (1997) 2165-2171
24. Hubbard W.C., Kee C., and Kaufman P.L. Aceclidine effects on outflow facility after ciliary muscle disinsertion. Ophthalmologica 210 (1996) 303-307
25. Johnson D.H., and Tschumper R.C. Human trabecular meshwork organ culture: a new method. Invest. Ophthalmol. Vis. Sci. 28 (1987) 945-953
26. Johnson M., Chen A., Epstein D.L., and Kamm R.D. The pressure and volume dependence of the rate of washout in the bovine eye. Curr. Eye Res. 10 (1991) 373-375
27. Kaufman P.L., and Bárány E.H. Loss of acute pilocarpine effect on outflow facility following surgical disinsertion and retrodisplacement of the ciliary muscle from the scleral spur in the cynomolgus monkey. Invest. Ophthalmol. 15 (1976) 793-807
28. Kaufman P.L., Lütjen-Drecoll E., Hubbard W.C., and Erickson K.A. Obstruction of aqueous humor outflow by cross-linked polyacrylamide microgels in bovine, monkey and human eyes. Ophthalmology 101 (1994) 1672-1679
29. Khurana R.N., Deng P.F., Epstein D.L., and Vasantha Rao P. The role of protein kinase C in modulation of aqueous humor outflow facility. Exp. Eye Res. 76 (2003) 39-47
30. Kiland J.A., Croft M.A., Gabelt B.T., and Kaufman P.L. Atropine reduces but does not eliminate the age-related decline in perfusion outflow facility in monkeys. Exp. Eye Res. 64 (1997) 831-835
31. Kiland J.A., Peterson J.A., Gabelt B.T., and Kaufman P.L. Effect of DMSO and exchange volume on outflow resistance washout and response to pilocarpine during anterior chamber perfusion in monkeys. Curr. Eye Res. 16 (1997) 1215-1220
32. Llobet A., Gual A., Pales J., Barraquer R., Tobias E., and Nicolas J.M. Bradykinin decreases outflow facility in perfused anterior segments and induces shape changes in passaged BTM cells in vitro. Invest. Ophthalmol. Vis. Sci. 40 (1999) 113-125
33. Lütjen-Drecoll E., and Rohen J.W. Morphologic basis for drug action on aqueous outflow. In: Drance S.M. (Ed). Applied Pharmacology in the Medical Treatment of Glaucomas (1984), Grune & Stratton, Inc., New York 459-475
34. Mettu P.S., Deng P.F., Misra U.K., Gawdi G., Epstein D.L., and Rao P.V. Role of lysophospholipid grwoth factors in the modulation of aqueous humor outflow facility. Invest. Ophthalmol. Vis. Sci. 45 (2004) 2263-2271
35. Overby D., Gong H., Qiu G., Freddo T.F., and Johnson M. The mechanism of increasing outflow facility during washout in the bovine eye. Invest. Ophthalmol. Vis. Sci. 42 (2002) 3455-3464
36. Pang I.H., Moll H., McLaughlin M.A., Knepper P.A., De Santis L., Epstein D.L., and Clark A.F. Ocular hypotensive and aqueous outlfow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate). Exp. Eye Res. 73 (2001) 815-825
37. Pang I.H., Fleenor D.L., Hellberg P.E., Storpki K., McCartney M.D., and Clark A.F. Aqueous outflow-enhancing effect of tert-butylhydroquinone: involvement of AP-1 activation and MMP-3 expression. Invest. Ophthalmol. Vis. Sci. 44 (2003) 3502-3510
38. Quinn R.F., and Tingey D.P. Effects of cytoskeleton-reactive agents on aqueous outflow facility in a porcine ocular anterior segment preparation. Can. J. Ophthalmol. 30 (1995) 4-10
39. Rao P.V., Deng P.-F., Kumar J., and Epstein D.L. Modulation of aqueous humor outflow facility by the rho kinase-specific inhibitor Y-27632. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1029-1037
40. Rao P.V., Deng P., Sasaki Y., and Epstein D.L. Regulation of myosin light chain phosphorylation in the trabecular meshwork: role in aqueous humour outflow facility. Exp. Eye Res. 80 (2005) 197-206
41. Rohen J.W. The evolution of the primate eye in relation to the problem of glaucoma. In: Lutjen-Drecoll E. (Ed). Basic Aspects of Glaucoma Research (1982), Schattauer, Stuttgart 3-33
42. Rohen J.W., Lütjen E., and Bárány E. The relation between the ciliary muscle and the trabecular meshwork and its importance for the effect of miotics on aqueous outflow resistance. Albrecht von Graefes Arch. Klin. Exp. Ophthalmol. 172 (1967) 23-47
43. Rohen J.W., Futa R., and Lütjen-Drecoll E. The fine structure of the cribriform meshwork in normal and glaucomatous eye as seen in tangential sections. Invest. Ophthalmol. Vis. Sci. 21 (1981) 574-585
44. Sabanay I., Gabelt B.T., Tian B., Kaufman P.L., and Geiger B. H-7 effects on structure and fluid conductance of monkey trabecular meshwork. Arch. Ophthalmol. 118 (2000) 955-962
45. Sabanay I., Tian B., Gabelt B.T., Geiger B., and Kaufman P.L. Functional and structural reversibility of H-7 effects on the conventional aqueous outflow pathway in monkeys. Exp. Eye Res. 78 (2004) 137-150
46. Santas A.J., Bahler C., Peterson J.A., Filla M.S., Kaufman P.L., Tamm E.R., Johnson D.H., and Peters D.M. Effect of heparin II domain of fibronectin on aqueous outflow in cultured anterior segments of human eyes. Invest. Ophthalmol. Vis. Sci. 44 (2003) 4796-4804
47. Schuman J.S., Chang W., Wang N., de Kater A.W., and Allingham R.R. Excimer laser effects on outflow facility and outflow pathway morphology. Invest. Ophthalmol. Vis. Sci. 40 (1999) 1676-1680
48. Sit A.J., Gong H., Ritter N., Freddo T.F., Kamm R., and Johnson M. The role of soluble proteins in generating aqueous outflow resistance in the bovine and human eye. Exp. Eye Res. 64 (1997) 813-821
49. Soto D., Comes N., Ferrer E., Morales M., Escalada A., Pales J., Solsona C., Gual A., and Gasull X. Modulation of aqueous humor outflow by ionic mechanisms involved in trabecular meshwork cell volume regulation. Invest. Ophthalmol. Vis. Sci. 45 (2004) 3650-3661
50. Suzuki R., Karageuzian L.N., Crean E.V., and Anderson P.J. Effects of adrenergic agents and phosphodiesterase inhibitors on outflow facility and cell shape of bovine trabecular meshwork. Jpn. J. Ophthalmol. 41 (1997) 31-37
51. Tian B., Kaufman P.L., Volberg T., Gabelt B.T., and Geiger B. H-7 disrupts the actin cytoskeleton and increases outflow facility. Arch. Opthalmol. 116 (1998) 633-643
52. Tian B., Gabelt B.T., Peterson J.A., Kiland J.A., and Kaufman P.L. H-7 increases trabecular facility and facility after ciliary muscle disinsertion in monkeys. Invest. Ophthalmol. Vis. Sci. 40 (1999) 239-242
53. Yoshino H., and Suzuki R. Effect of phosphodiesterase inhibitors on bovine ciliary muscle and outflow facility. J. Ocul. Pharmacol. 8 (1992) 99-105